Bridgewater Associates’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-134,657
Closed -$3.73M 818
2023
Q2
$3.73M Sell
134,657
-8,055
-6% -$263K 0.02% 359
2023
Q1
$4.75M Sell
142,712
-332,300
-70% -$12.8M 0.03% 318
2022
Q4
$14.6M Sell
475,012
-195,553
-29% -$6.17M 0.08% 192
2022
Q3
$22.9M Buy
670,565
+33,384
+5% +$1.43M 0.12% 142
2022
Q2
$22.1M Buy
637,181
+283,213
+80% +$9.99M 0.09% 188
2022
Q1
$15.6M Buy
353,968
+157,824
+80% +$7.63M 0.06% 213
2021
Q4
$12.3M Buy
196,144
+37,656
+24% +$3.19M 0.07% 166
2021
Q3
$16.7M Buy
158,488
+63,908
+68% +$9.17M 0.09% 143
2021
Q2
$16.7M Sell
94,580
-2,998
-3% -$482K 0.11% 147
2021
Q1
$13M Sell
97,578
-34,646
-26% -$5.36M 0.11% 140
2020
Q4
$17.9M Buy
132,224
+25,455
+24% +$2.59M 0.15% 90
2020
Q3
$8.88M Buy
106,769
+42,932
+67% +$3.45M 0.11% 92
2020
Q2
$5.24M Buy
+63,837
New +$4.32M 0.09% 50

Other funds holding ZLAB

Bridgewater Associates's ZLAB Position: Q3 2023 in Review

Bridgewater Associates sold out of Zai Lab (ZLAB) in Q3 2023, closing a stake of 134,657 shares — an estimated $3.73M sold.

Bridgewater Associates first reported a position in ZLAB in Q2 2020 and held it in 13 quarters. The position peaked at $22.9M in Q3 2022. 121 funds tracked by Wall St. Rank hold ZLAB as of Q3 2023.

  • Bridgewater Associates reported no remaining Zai Lab position as of Q3 2023 after selling out during the quarter.
  • Bridgewater Associates sold 134,657 Zai Lab shares in Q3 2023, an estimated $3.73M.
  • Bridgewater Associates first reported a position in Zai Lab in Q2 2020 and held it in 13 quarters.
  • Bridgewater Associates's Zai Lab position peaked at $22.9M in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Zai Lab as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.